Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

13.3K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.3K
Mixtures of Acids03:27

Mixtures of Acids

21.9K
The pH of a solution containing an acid can be determined using its acid dissociation constant and its initial concentration. If a solution contains two different acids, then its pH can be determined using one of several methods depending upon the relative strength of the acids and their dissociation constants.
A Mixture of a Strong Acid and a Weak Acid
In a mixture of a strong acid and a weak acid, the strong acid dissociates completely and becomes a source of almost all the hydronium ions...
21.9K
Mixtures of Acids01:19

Mixtures of Acids

1.1K
The pH of a solution containing an acid can be determined using its acid dissociation constant and initial concentration. If a solution contains two different acids, then its pH can be determined using one of several methods depending on the relative strength of the acids and their dissociation constants.
In a strong and weak acid mixture, the strong acid dissociates completely and becomes a source of almost all the hydronium ions present in the solution. In contrast, the weak acid shows...
1.1K
Longitudinal Studies01:26

Longitudinal Studies

533
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
533
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

810
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
810
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

277
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
277

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Covariate modeling in pharmacometrics: General points for consideration.

CPT: pharmacometrics & systems pharmacology·2024
Same author

Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation.

European journal of clinical pharmacology·2024
Same author

Correction to: Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials.

Journal of pharmacokinetics and pharmacodynamics·2023
Same author

Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials.

Journal of pharmacokinetics and pharmacodynamics·2023
Same author

Population Pharmacokinetic Modeling for Ceftazidime-Avibactam Renal Dose Adjustments in Pediatric Patients 3 months and Older.

Clinical pharmacology and therapeutics·2022
Same author

Maraviroc Population Pharmacokinetics Within the First 6 Weeks of Life.

The Pediatric infectious disease journal·2022
Same journal

Optimizing Subcutaneous Antibody Dosing Regimens Through Operating Space Maps: rHuPH20 Case Study.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Mechanistic modeling of FcRn-dependent IgG drug interactions: Clinical applications and dosing implications.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Comparing heavy-tailed residual error models for outlier handling in population PK modeling.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Personalized prophylactic therapy optimization in hemophilia A using a hybrid PK-PD-TTE model and deep RL.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Pediatric oral cavity physiologically based pharmacokinetic model to predict pharmacokinetics of mucoadhesive atropine gel to treat sialorrhea.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial.

Journal of pharmacokinetics and pharmacodynamics·2026
See all related articles

Related Experiment Video

Updated: Feb 6, 2026

Author Spotlight: Exploring Microglial Interactions with Stress-Response Circuitry Using the Limited Bedding and Nesting Model
04:20

Author Spotlight: Exploring Microglial Interactions with Stress-Response Circuitry Using the Limited Bedding and Nesting Model

Published on: July 12, 2024

2.6K

A two-part mixture model for longitudinal adverse event severity data.

Kenneth G Kowalski1, Lynn McFadyen, Matthew M Hutmacher

  • 1Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA. ken.kowalski@pfizer.com

Journal of Pharmacokinetics and Pharmacodynamics
|February 24, 2004
PubMed
Summary
This summary is machine-generated.

A novel two-part mixture model addresses extreme bimodality in adverse event (AE) severity data. This approach improves statistical performance and predictive accuracy for investigational drug safety assessments.

More Related Videos

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
07:45

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment

Published on: November 6, 2018

10.2K
High Density Event-related Potential Data Acquisition in Cognitive Neuroscience
08:33

High Density Event-related Potential Data Acquisition in Cognitive Neuroscience

Published on: April 16, 2010

13.0K

Related Experiment Videos

Last Updated: Feb 6, 2026

Author Spotlight: Exploring Microglial Interactions with Stress-Response Circuitry Using the Limited Bedding and Nesting Model
04:20

Author Spotlight: Exploring Microglial Interactions with Stress-Response Circuitry Using the Limited Bedding and Nesting Model

Published on: July 12, 2024

2.6K
Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
07:45

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment

Published on: November 6, 2018

10.2K
High Density Event-related Potential Data Acquisition in Cognitive Neuroscience
08:33

High Density Event-related Potential Data Acquisition in Cognitive Neuroscience

Published on: April 16, 2010

13.0K

Area of Science:

  • Biostatistics
  • Pharmacovigilance
  • Clinical Trial Analysis

Background:

  • Mixed effects logistic regression models are commonly used for longitudinal adverse event (AE) severity data.
  • Extreme bimodality in predicted random effects distributions can lead to biased parameter estimates and poor predictive performance.
  • Investigational drug safety assessments require accurate modeling of dose-response relationships for adverse events.

Purpose of the Study:

  • To address the issue of extreme bimodality in the distribution of predicted interindividual random effects from a mixed effects logistic regression model.
  • To propose and evaluate a two-part mixture modeling approach for analyzing longitudinal AE severity data.
  • To improve the statistical and predictive performance of AE severity modeling in clinical trials.

Main Methods:

  • A mixed effects logistic regression model was initially fitted to four-point ordered categorical AE severity data.
  • A novel two-part mixture model was developed, with the first part modeling AE incidence and the second modeling severity grade.
  • Simulation studies were conducted to assess the predictive and statistical performance (bias, precision) of the proposed approach.

Main Results:

  • The initial mixed effects model exhibited extreme bimodality in predicted random effects, suggesting potential estimation and prediction issues.
  • The proposed two-part mixture model effectively resolved the bimodality issue.
  • Simulation studies demonstrated favorable predictive and statistical performance of the two-part mixture approach.

Conclusions:

  • The two-part mixture modeling approach offers a robust solution for analyzing longitudinal AE severity data with extreme bimodality.
  • This method enhances the reliability of dose-AE severity response assessments for investigational drugs.
  • The proposed approach improves the accuracy of safety profile evaluations in clinical research.